홈 > 시장보고서 > 의료기기 > 바이오장비

시장보고서

상품코드

1389672

ELISA 진단 검사 시장 규모 및 예측, 세계 및 지역 점유율, 동향, 성장 기회 분석 보고서 : 채용, 검사 유형, 용도, 최종 사용자, 지역별

ELISA Diagnostic Test Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption, Test Type, Application, End User, and Geography

발행일: 2023년 11월 | 리서치사:

The Insight Partners | 페이지 정보: 영문 199 Pages | 배송안내 : 즉시배송

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

ELISA 진단 테스트 시장은 2022년 12억 8,549만 달러에서 2030년 22억 7,123만 달러로 성장할 것으로 예상되며, 2022-2030년간 7.37%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다. 시장 개척의 주요 원동력은 동물 간 감염 증가와 사람에 대한 감염 발생률 증가입니다.

효소 결합 면역 흡착 분석법(ELISA)은 환자의 혈액에서 항체를 검출하고 측정하는 검사 방법입니다. ELISA 검사는 에이즈를 유발하는 HIV, 라임병, 악성 빈혈, 로타 바이러스 등을 진단하는 데 사용되며, ELISA 키트는 샘플이나 배양물에서 특정 표적을 신속하고 정확하게 검출하고 정량화할 수 있는 귀중한 조사 도구이다, 신속, 간편하고 정확하게 검출 및 정량할 수 있는 귀중한 조사 도구입니다. 시중에서 판매되는 ELISA 키트에는 프리코팅 플레이트, 포획/검출 항체, 표준품, 완충액 및 기타 필요한 시약이 포함되어 있습니다. 각 키트는 정확성, 정밀도, 민감도, 특이성 및 재현성을 보장하기 위해 엄격한 검증 및 안정성 테스트를 거쳤습니다.

혁신적인 제품 출시는 ELISA 진단 검사 시장에 기회를 제공합니다.

ELISA 방법은 유연성, 민감도, 사용 편의성 등 다양한 장점으로 인해 가장 인기 있는 면역 측정 방법 중 하나입니다. 또한, ELISA 검사 키트의 저렴한 비용과 높은 처리량 검사에 따른 다면적 적용성으로 인해 다양한 연구 및 IVD 요구 사항에 이상적인 솔루션이 되었습니다. 저비용 적용성으로 인해 검사 키트의 제품 혁신은 인간 및 동물 연구에 대한 수요를 증가시키고 있습니다. 또한 각 제조업체는 자체 설비를 갖춘 ELISA 검사 키트 개발에 주력하고 있습니다.

Innovative Research는 응고인자, 생물종, 항체의 동정을 위한 광범위한 선택성을 가진 ELISA 키트를 판매하고 있습니다. '인간 혈액응고 제IX인자 키트'도 그 중 하나입니다. 인간 응고 제IX인자 항원 분석은 인간 혈장 내 전체 제IX인자 항원을 정량하는 것을 목적으로 합니다. 이 키트는 연구 목적으로만 사용하도록 권장되며, 시약은 최대 96개의 임상 검사에 사용할 수 있습니다.

또한, 코로나19의 대유행 속에서 각 제조업체들이 혁신적인 ELISA 검사 제품을 출시하면서 인간을 대상으로 한 ELISA 검사의 보급이 가속화되고 있습니다.

2022년 12월, Pictor Limited는 'PictArray SARS-CoV-2 항체 검사' 신제품을 발표했습니다. 이 신제품은 코로나19 바이러스 관련 감염을 감지하고, 얻은 임상 결과는 환자와 의사가 SARS-CoV-2 감염을 치료하고 관리하는 데 도움이 될 수 있습니다. 제조업체의 혁신적인 ELISA 검사 키트의 출시는 저렴한 비용으로 다면적인 적용이 가능하며, 다양한 생물종과 관련된 다양한 감염증의 진단에 효과적인 임상 결과를 제공할 것으로 기대됩니다. 이처럼 혁신적인 제품의 출시는 장기적으로 제조업체에 유리한 기회를 제공할 것으로 보입니다.

시장 동향

ELISA 기반 절차의 발전

ELISA를 이용한 체외진단(IVD)은 세계 시장에서 큰 주목을 받고 있습니다. 다양한 분야의 연구자들은 자기 비드, 종이 기반 플랫폼, 나노 물질과 같은 기술을 통해 ELISA 기반 절차의 개발 및 적용에 매력을 느끼고 있습니다. 기술 기반 ELISA 키트의 다른 예로는 디지털 ELISA, 멀티플렉스 ELISA, 단일 분자 ELISA, 나노 입자 기반 ELISA, 스마트폰 기반 ELISA 등이 있습니다. 또한, 신속하고 효율적인 임상 결과를 얻기 위해 각 업체들은 여러 기술 기반의 ELISA 검사 키트를 출시하고 있는데, 'AMP'D ELISA 신호 증폭 시스템'은 Enzo Life Sciences, Inc. 샌드위치 ELISA 테스트 유형의 민감도를 효율적으로 향상시켜 고감도를 제공합니다.

Cell Signaling Technology, Inc.가 설계한 'PathScan Phospho-RSK1(Ser380) Sandwich ELISA Kit'도 기술을 활용한 ELISA 검사 키트 제품 중 하나입니다. 이러한 첨단 기술 기반의 ELISA 검사 키트 제품은 향후 수의사 및 인체 관련 감염 및 질병을 유발하는 다양한 종을 검출하기 위해 수의사들 수요가 높을 것으로 예상됩니다. 따라서 ELISA 기반 절차의 발전은 2020-2030년 ELISA 진단 검사 시장의 성장을 강화할 것으로 예상됩니다.

용도별 인사이트

용도별로 ELISA 진단 테스트 시장은 자가면역질환, 감염성 질환, 암 진단, 단백질 정량 및 기타로 분류됩니다. 감염 분야는 2022년 시장에서 가장 큰 점유율을 차지할 것으로 예상되며, 2022-2030년 시장 CAGR은 8.43%입니다. ELISA는 면역학에서 항체 및 항원 검출, 알레르기 검사 및 자가면역질환 진단을 위한 강력한 기술입니다. 고령화, 인구 통계 및 라이프스타일의 변화로 인해 세계적으로 자가면역질환 및 바이러스성 질환(HIV, STI, B형 간염 등)의 발병률이 증가하고 있는 것이 세계 ELISA 진단 검사 시장의 성장을 가속하고 있습니다. 발표한 통계에 따르면, 자가면역질환은 80가지 이상의 질병으로 세계 인구의 4%가 앓고 있는 것으로 나타났습니다. 가장 흔한 자가면역질환은 제1형 당뇨병, 다발성 경화증, 류마티스 관절염, 루푸스, 크론병, 건선, 피부경화증 등입니다. 미국에서는 자가면역질환이 만성질환의 세 번째 원인으로 꼽힙니다. 드물지만, 이들 질환을 합치면 미국 인구의 5-8%가 앓고 있는 것으로 추정됩니다. 예를 들어, 2022년 5월 PubMed Central에 발표된 논문에 따르면, 자가면역성 수포성 질환(AIBD) 특이 항체의 전통적인 혈청학적 검출은 조직 기질을 이용한 1차 스크리닝에 이어 ELISA와 같은 항원 특이적 분석이 이루어집니다.

또한, 차세대 면역진단 플랫폼 개발 등 다양한 기술 발전이 시장 성장을 가속할 것으로 예상됩니다.

검사 유형별로는 샌드위치 ELISA, 간접 ELISA, 경쟁 ELISA, 다중 및 휴대용 ELISA로 분류되며, 2022년 시장 점유율은 간접 ELISA가 가장 크고, 2022-2030년 CAGR이 가장 높을 것으로 예상됩니다.

ELISA 진단 테스트 시장은 최종 사용자별로 병원 및 진단센터, 제약 및 생명공학 기업, 동물병원 및 진단 실험실, 기타로 분류됩니다. 병원 및 진단센터 부문이 2020-2030년 시장 점유율에서 가장 큰 비중을 차지할 것으로 추정됩니다.

The ELISA Diagnostic Test Market is expected to grow from US$ 1,285.49 million in 2022 to US$ 2,271.23 million by 2030; it is estimated to register a CAGR of 7.37% from 2022 to 2030. Key driving factors behind the market development are the rising infectious diseases among animals and the increasing incidence of human infections are the key driving factors behind the market development.

An enzyme-linked immunosorbent assay (ELISA) is a test that detects and measures antibodies in a patient's blood. This test can be used to determine if the patient has antibodies related to certain infectious conditions. An ELISA test is used to diagnose HIV causing AIDS, Lyme disease, pernicious anemia, rotavirus, and among others. ELISA kits are a valuable research tool that offer quick, convenient, and precise detection and quantitation of specific targets in samples and cultures. Commercially available ELISA kits come with pre-coated plates, capture/detection antibodies, standards, buffers, and other necessary reagents. Each kit undergoes rigorous validation and stability testing to ensure accuracy, precision, sensitivity, specificity, and reproducibility.

Innovative Product Launches Creates Opportunities in ELISA Diagnostic Test Market.

ELISA is one of the most popular immunoassay tests owing to its various advantages such as flexibility, sensitivity, and easy-to-use features. Also, low cost of ELISA test kit and multifaceted applicability associated with high-throughput testing make it an ideal solution for various research and IVD requirements. With low-cost applicability, product innovations in the test kits enhance the demand for human and animal research. Also, manufacturers focus on developing ELISA test kits with in-house facilities.

Innovative Research company sells a wide range of ELISA kits with selectivity to a broad range in identifying coagulants, species, and antibodies. "Human Factor IX Kit" is one such example manufactured by Innovative Research. The human coagulation Factor IX antigen assay is intended for the quantitative determination of total Factor IX antigen in human plasma. The kit is recommended to use only for research purposes, and reagents can be utilized for up to 96 clinical tests.

Additionally, innovative product launches for ELISA tests by the manufacturers amid the COVID-19 pandemic accelerate the adoption of ELISA testing among humans.

In December 2022, Pictor Limited announced a new product launch of the "PictArray SARS-CoV-2 Antibody Test," which has demonstrated real clinical utility intended for patients and doctors. The new product detects the infection associated with the COVID-19 virus, and the clinical results produced assist the patients and doctors in treating and managing SARS-CoV-2 infection. Launches of innovative ELISA test kits by manufacturers are expected to provide effective clinical results for diagnosing varied infections associated with different types of species with low cost and multifaceted applications. Thus, innovative product launches would provide lucrative opportunities for manufacturers in the long run.

Market Trend

Advancements in ELISA-Based Procedures

The use of ELISA for in-vitro diagnostics (IVD) has gained considerable attention in the global market. Researchers from various fields have been attracted to the development and application of ELISA-based procedures through techniques such as magnetic beads, paper-based platforms, and nanomaterials. Other examples of technology-based ELISA kits are digital ELISA, Multiplex ELISA, Single-Molecule ELISA, Nanoparticle-Based ELISA, and Smartphone-Based ELISA. Also, companies launch ELISA testing kits based on several techniques for fast and efficient clinical results. The "AMP'D ELISA Signal Amplification system" is manufactured by Enzo Life Sciences, Inc. The AMP'D Technology efficiently improves the sensitivity of sandwich ELISA test type with a single amplification kit and offers high sensitivity.

Cell Signaling Technology, Inc.'s "PathScan Phospho-RSK1 (Ser380) Sandwich ELISA Kit," designed by Cell Signaling Technology, is another example of a technology-advanced ELISA test kit product. Such advanced technology-based ELISA test kit products will have a high demand in the future by veterinarians for the detection of different species responsible for veterinary and human-associated infections or diseases. Therefore, advancements in ELISA-based procedures are expected to bolster the ELISA diagnostic test market growth during 2020-2030.

Application-Based Insights

In terms of Application, the ELISA Diagnosis Test Market is categorized into autoimmune diseases, infectious disease, cancer diagnosis, protein quantification, and others. The infectious disease segment held the largest share of the market in 2022 and is anticipated to register the highest CAGR of 8.43% in the market during the 2022-2030. ELISA is a powerful technique in immunology for detecting antibodies and antigens and performing allergy testing and autoimmune disease diagnosis. The growing incidence of autoimmune diseases, and viral diseases (HIV, STI, hepatitis B, and others) across the world owing to the aged population and changes in demographics and lifestyle is driving the growth of the global ELISA diagnostic testing market. As per the statistics given by National Stem Cell Foundation in 2023, autoimmune diseases affect more than 80 different types of diseases and nearly 4% of the world's population. The most common autoimmune diseases include type 1 diabetes, multiple sclerosis, rheumatoid arthritis, lupus, Crohn's disease, psoriasis, and scleroderma. In the United States, autoimmune diseases are the third most common cause of chronic illness. Although rare, collectively, these diseases affect between 5% and 8% of the US population. For instance, according to an article published by PubMed Central in May 2022, conventional serological detection of Autoimmune bullous disease (AIBD) specific antibodies involves an initial screening using tissue substrates, followed by an antigen-specific assay such as ELISA.

Moreover, various technological advancements, such as the development of next-generation immunodiagnostics platforms, are anticipated to drive the market growth.

Based on test type, is segregated as sandwich ELISA, indirect ELISA, competitive ELISA, and multiple & portable ELISA. The indirect ELISA segment held a larger market share in 2022 and the same segment is anticipated to register a higher CAGR during 2022-2030.

The ELISA diagnostic test market, by end user, is categorized as hospitals & diagnostic centers, pharmaceutical & biotechnology companies, veterinary hospital & diagnostic laboratories, and others. The hospital & diagnostic centers segment held the largest share of the market during 2020-2030.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the ELISA diagnostic test market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global ELISA diagnostic test market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global ELISA diagnostic test market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
- 1.2.1 Global ELISA Diagnostic Tests Market - by Adoption
- 1.2.2 Global ELISA Diagnostic Tests Market - by Test Type
- 1.2.3 Global ELISA Diagnostic Tests Market - by Application
- 1.2.4 Global ELISA Diagnostic Tests Market - by End User
- 1.2.5 Global ELISA Diagnostic Tests Market - by Region

2. Executive Summary

2.1 Key Insights
2.2 ELISA Diagnostic Test Market, by Geography (US$ Million)

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. ELISA Diagnostic Test Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 PEST Analysis

5. ELISA Diagnostic Test Market - Key Industry Dynamics

5.1 Key Market Drivers
- 5.1.1 Rising Infectious Diseases Among Animals
- 5.1.2 Increasing Incidence of Human Infections
5.2 Key Market Restraints
- 5.2.1 Incidents of Product Recalls
5.3 Key Market Opportunities
- 5.3.1 Innovative Product Launches
5.4 Future Trends
- 5.4.1 Advancements in ELISA-Based Procedures

6. ELISA Diagnostic Tests Market - Global Market Analysis

6.1 ELISA Diagnostic Tests Market Revenue (US$ Mn), 2022 - 2030

7. Global ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - by Adoption

7.1 Overview
7.2 ELISA Diagnostic Tests Market Revenue Share, by Adoption 2022 & 2030 (%)
7.3 Human
- 7.3.1 Overview
- 7.3.2 Human: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Veterinary
- 7.4.1 Overview
- 7.4.2 Veterinary: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)

8. Global ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - by Test Type

8.1 Overview
8.2 ELISA Diagnostic Tests Market Revenue Share, by Test Type 2022 & 2030 (%)
8.3 Sandwich ELISA
- 8.3.1 Overview
- 8.3.2 Sandwich ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Indirect ELISA
- 8.4.1 Overview
- 8.4.2 Indirect ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Competitive ELISA
- 8.5.1 Overview
- 8.5.2 Competitive ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Multiple & Portable ELISA
- 8.6.1 Overview
- 8.6.2 Multiple & Portable ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)

9. Global ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - by Application

9.1 Overview
9.2 ELISA Diagnostic Tests Market Revenue Share, by Application 2022 & 2030 (%)
9.3 Autoimmune Diseases
- 9.3.1 Overview
- 9.3.2 Autoimmune Diseases: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Infectious Disease
- 9.4.1 Overview
- 9.4.2 Infectious Disease: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Cancer Diagnosis
- 9.5.1 Overview
- 9.5.2 Cancer Diagnosis: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Protein Quantification
- 9.6.1 Overview
- 9.6.2 Protein Quantification: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
9.7 Others
- 9.7.1 Overview
- 9.7.2 Others: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)

10. Global ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - by End User

10.1 Overview
10.2 ELISA Diagnostic Tests Market Revenue Share, by End User 2022 & 2030 (%)
10.3 Hospitals & Diagnostic Centers
- 10.3.1 Overview
- 10.3.2 Hospitals & Diagnostic Centers: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Pharmaceutical & Biotechnology Companies
- 10.4.1 Overview
- 10.4.2 Pharmaceutical & Biotechnology Companies: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Veterinary Hospitals & Diagnostic Laboratories
- 10.5.1 Overview
- 10.5.2 Veterinary Hospitals & Diagnostic Laboratories: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
10.6 Others
- 10.6.1 Overview
- 10.6.2 Others: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)

11. ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - Geographic Analysis

11.1 North America: ELISA Diagnostic Tests Market
- 11.1.1 Overview
- 11.1.2 North America: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- 11.1.3 North America: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
- 11.1.4 North America: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
- 11.1.5 North America: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
- 11.1.6 North America: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
- 11.1.7 North America: ELISA Diagnostic Tests Market, by Country
  - 11.1.7.1 US: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.1.7.1.1 Overview
    - 11.1.7.1.2 US: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.1.7.1.3 US: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
    - 11.1.7.1.4 US: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
    - 11.1.7.1.5 US: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
    - 11.1.7.1.6 US: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
  - 11.1.7.2 Canada: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.1.7.2.1 Overview
    - 11.1.7.2.2 Canada: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.1.7.2.3 Canada: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
    - 11.1.7.2.4 Canada: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
    - 11.1.7.2.5 Canada: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
    - 11.1.7.2.6 Canada: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
  - 11.1.7.3 Mexico: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.1.7.3.1 Overview
    - 11.1.7.3.2 Mexico: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.1.7.3.3 Mexico: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
    - 11.1.7.3.4 Mexico: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
    - 11.1.7.3.5 Mexico: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
    - 11.1.7.3.6 Mexico: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
11.2 Europe: ELISA Diagnostic Tests Market
- 11.2.1 Overview
- 11.2.2 Europe: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- 11.2.3 Europe: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
- 11.2.4 Europe: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
- 11.2.5 Europe: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
- 11.2.6 Europe: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
- 11.2.7 Europe: ELISA Diagnostic Tests Market, by Country
  - 11.2.7.1 Germany: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.7.1.1 Overview
    - 11.2.7.1.2 Germany: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.7.1.3 Germany: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
    - 11.2.7.1.4 Germany: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
    - 11.2.7.1.5 Germany: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
    - 11.2.7.1.6 Germany: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
  - 11.2.7.2 France: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.7.2.1 Overview
    - 11.2.7.2.2 France: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.7.2.3 France: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
    - 11.2.7.2.4 France: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
    - 11.2.7.2.5 France: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
    - 11.2.7.2.6 France: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
  - 11.2.7.3 UK: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.7.3.1 Overview
    - 11.2.7.3.2 UK: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.7.3.3 UK: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
    - 11.2.7.3.4 UK: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
    - 11.2.7.3.5 UK: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
    - 11.2.7.3.6 UK: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
  - 11.2.7.4 Italy: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.7.4.1 Overview
    - 11.2.7.4.2 Italy: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.7.4.3 Italy: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
    - 11.2.7.4.4 Italy: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
    - 11.2.7.4.5 Italy: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
    - 11.2.7.4.6 Italy: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
  - 11.2.7.5 Spain: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.7.5.1 Overview
    - 11.2.7.5.2 Spain: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.7.5.3 Spain: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
    - 11.2.7.5.4 Spain: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
    - 11.2.7.5.5 Spain: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
    - 11.2.7.5.6 Spain: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
  - 11.2.7.6 Rest of Europe: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.7.6.1 Overview
    - 11.2.7.6.2 Rest of Europe: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.7.6.3 Rest of Europe: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
    - 11.2.7.6.4 Rest of Europe: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
    - 11.2.7.6.5 Rest of Europe: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
    - 11.2.7.6.6 Rest of Europe: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
11.3 Asia Pacific: ELISA Diagnostic Tests Market
- 11.3.1 Overview
- 11.3.2 Asia Pacific: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- 11.3.3 Asia Pacific: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
- 11.3.4 Asia Pacific: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
- 11.3.5 Asia Pacific: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
- 11.3.6 Asia Pacific: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
- 11.3.7 Asia Pacific: ELISA Diagnostic Tests Market, by Country
  - 11.3.7.1 China: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.7.1.1 Overview
    - 11.3.7.1.2 China: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.7.1.3 China: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
    - 11.3.7.1.4 China: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
    - 11.3.7.1.5 China: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
    - 11.3.7.1.6 China: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
  - 11.3.7.2 Japan: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.7.2.1 Overview
    - 11.3.7.2.2 Japan: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.7.2.3 Japan: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
    - 11.3.7.2.4 Japan: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
    - 11.3.7.2.5 Japan: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
    - 11.3.7.2.6 Japan: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
  - 11.3.7.3 India: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.7.3.1 Overview
    - 11.3.7.3.2 India: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.7.3.3 India: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
    - 11.3.7.3.4 India: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
    - 11.3.7.3.5 India: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
    - 11.3.7.3.6 India: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
  - 11.3.7.4 Australia: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.7.4.1 Overview
    - 11.3.7.4.2 Australia: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.7.4.3 Australia: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
    - 11.3.7.4.4 Australia: ELISA Diagnostic Tests Market, by Test Type , 2020-2030 (US$ Million)
    - 11.3.7.4.5 Australia: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
    - 11.3.7.4.6 Australia: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
  - 11.3.7.5 South Korea: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.7.5.1 Overview
    - 11.3.7.5.2 South Korea: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.7.5.3 South Korea: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
    - 11.3.7.5.4 South Korea: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
    - 11.3.7.5.5 South Korea: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
    - 11.3.7.5.6 South Korea: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
  - 11.3.7.6 Rest of Asia Pacific: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.7.6.1 Overview
    - 11.3.7.6.2 Rest of Asia Pacific: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.7.6.3 Rest of Asia Pacific: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
    - 11.3.7.6.4 Rest of Asia Pacific: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
    - 11.3.7.6.5 Rest of Asia Pacific: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
    - 11.3.7.6.6 Rest of Asia Pacific: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
11.4 Middle East & Africa: ELISA Diagnostic Tests Market
- 11.4.1 Overview
- 11.4.2 Middle East & Africa: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- 11.4.3 Middle East & Africa: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
- 11.4.4 Middle East & Africa: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
- 11.4.5 Middle East & Africa: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
- 11.4.6 Middle East & Africa: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
- 11.4.7 Middle East & Africa: ELISA Diagnostic Tests Market, by Country
  - 11.4.7.1 South Africa: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.4.7.1.1 Overview
    - 11.4.7.1.2 South Africa: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.4.7.1.3 South Africa: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
    - 11.4.7.1.4 South Africa: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
    - 11.4.7.1.5 South Africa: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
    - 11.4.7.1.6 South Africa: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
  - 11.4.7.2 Saudi Arabia: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.4.7.2.1 Overview
    - 11.4.7.2.2 Saudi Arabia: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.4.7.2.3 Saudi Arabia: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
    - 11.4.7.2.4 Saudi Arabia: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
    - 11.4.7.2.5 Saudi Arabia: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
    - 11.4.7.2.6 Saudi Arabia: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
  - 11.4.7.3 UAE: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.4.7.3.1 Overview
    - 11.4.7.3.2 UAE: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.4.7.3.3 UAE: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
    - 11.4.7.3.4 UAE: ELISA Diagnostic Tests Market, by Test Type , 2020-2030 (US$ Million)
    - 11.4.7.3.5 UAE: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
    - 11.4.7.3.6 UAE: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
  - 11.4.7.4 Rest of Middle East & Africa: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.4.7.4.1 Overview
    - 11.4.7.4.2 Rest of Middle East & Africa: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.4.7.4.3 Rest of Middle East & Africa: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
    - 11.4.7.4.4 Rest of Middle East & Africa: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
    - 11.4.7.4.5 Rest of Middle East & Africa: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
    - 11.4.7.4.6 Rest of Middle East & Africa: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
11.5 South & Central America: ELISA Diagnostic Tests Market
- 11.5.1 Overview
- 11.5.2 South & Central America: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- 11.5.3 South & Central America: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
- 11.5.4 South & Central America: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
- 11.5.5 South & Central America: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
- 11.5.6 South & Central America: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
- 11.5.7 South & Central America: ELISA Diagnostic Tests Market, by Country
  - 11.5.7.1 Brazil: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.5.7.1.1 Overview
    - 11.5.7.1.2 Brazil: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.5.7.1.3 Brazil: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
    - 11.5.7.1.4 Brazil: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
    - 11.5.7.1.5 Brazil: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
    - 11.5.7.1.6 Brazil: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
  - 11.5.7.2 Argentina: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.5.7.2.1 Overview
    - 11.5.7.2.2 Argentina: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.5.7.2.3 Argentina: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
    - 11.5.7.2.4 Argentina: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
    - 11.5.7.2.5 Argentina: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
    - 11.5.7.2.6 Argentina: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
  - 11.5.7.3 Rest of South & Central America: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.5.7.3.1 Overview
    - 11.5.7.3.2 Rest of South & Central America: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.5.7.3.3 Rest of South & Central America: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
    - 11.5.7.3.4 Rest of South & Central America: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
    - 11.5.7.3.5 Rest of South & Central America: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
    - 11.5.7.3.6 Rest of South & Central America: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)

12. ELISA Diagnostics Test Market-Industry Landscape

12.1 Overview
12.2 Growth Strategies in ELISA diagnostics test Market
12.3 Organic Growth Strategies
- 12.3.1 Overview
12.4 Inorganic Growth Strategies
- 12.4.1 Overview

13. Company Profiles

13.1 Bio-Rad Laboratories Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Idexx Laboratories Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 F. Hoffmann-La Roche Ltd
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Thermo Fisher Scientific Inc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Abbott Laboratories
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Danaher Corp
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Innovative Diagnostics SAS
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Pictor Ltd
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 DiaSorin SpA
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Elabscience Biotechnology Inc
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Financial Overview
- 13.10.4 SWOT Analysis
- 13.10.5 Key Developments
13.11 Bio-Techne Corp
- 13.11.1 Key Facts
- 13.11.2 Business Description
- 13.11.3 Products and Services
- 13.11.4 Financial Overview
- 13.11.5 SWOT Analysis
- 13.11.6 Key Developments

14. Appendix

14.1 About Us
14.2 Glossary of Terms

02-2025-2992
(주말 및 공휴일 제외)

라이선스 / 가격

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다.

US $ 4,450

￦ 6,285,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,450

￦ 9,110,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,450

￦ 11,935,000

※ 부가세 별도

ELISA 진단 검사 시장 규모 및 예측, 세계 및 지역 점유율, 동향, 성장 기회 분석 보고서 : 채용, 검사 유형, 용도, 최종 사용자, 지역별

ELISA Diagnostic Test Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption, Test Type, Application, End User, and Geography

목차

제1장 서론

제2장 주요 요약

제3장 조사 방법

제4장 ELISA 진단 검사 시장 구도

제5장 ELISA 진단 검사 시장 : 주요 산업 역학

제6장 ELISA 진단 검사 시장 : 세계 시장 분석

제7장 세계의 ELISA 진단 검사 시장 - 매출과 2030년까지 예측 : 채택별

제8장 세계의 ELISA 진단 검사 시장 - 매출과 2030년까지 예측 : 검사 유형별

제9장 세계의 ELISA 진단 검사 시장 - 매출과 2030년까지 예측 : 용도별

제10장 세계의 ELISA 진단 검사 시장 - 매출과 2030년까지 예측 : 최종사용자별

제11장 ELISA 진단 검사 시장 - 매출과 2030년까지 예측 : 지역별 분석

제12장 ELISA 진단 검사 시장-업계 상황

제13장 기업 개요

제14장 부록